採用

Senior Scientist, Antibody Production & Characterization
Massachusetts, United States
·
On-site
·
Full-time
·
1mo ago
必須スキル
Python
Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.
Position Summary
We are seeking a Lead Scientist to drive the evolution of Ginkgo’s automated antibody production and developability platforms. This role is pivotal in bridging complex antibody engineering, specifically bi- and multi-specific formats, with Ginkgo’s RAC (Reconfigurable Automation Cart) systems. The ideal candidate is a technical expert in antibody transfection, purification, and characterization who thrives on translating manual workflows into robust, automated pipelines.
Key Responsibilities
-
Lead method development and execution of antibody production and characterization on Ginkgo’s autonomous robotic labs using the RAC (reconfigurable automation cell) systems.
-
Optimize high-throughput transfection and purification protocols for complex modalities, including bi-specifics and multi-specifics, at various scales (96 wp, 24 wp, 6 wp), ensuring high purity and correct assembly.
-
Execute and automate standard developability suites (thermal stability, aggregation, polyreactivity, etc), binding assay (BLI, SPR) and functional assays (cell-based) to support rapid "Design-Build-Test" cycles.
-
Serve as the project lead for customer projects focused on antibody production and developability characterization.
-
Mentor junior scientists and contribute to scientific strategy and innovation.
-
Author technical reports, SOPs, and present findings to internal leadership and external customers
Required Qualifications
-
Ph.D. in Chemical Engineering, Bioengineering, Molecular Biology, or a related field with 2+ years of industry/academic experience in antibody production and characterization (or M.S. with 6+ years of industry/academic experience).
-
Direct experience with the production and purification of complex antibody formats (e.g., bi-specifics, VHH-Fcs). Experience with Protein A/G/L, IEX, and SEC, specifically in a high-throughput or automated context.
-
Demonstrated proficiency in antibody binding (SPR, BLI) and developability (DSF, DLS, SEC, HIC, AC-SINS, Polyreactivity, etc.) assays
-
Demonstrated proficiency in using automated liquid handlers such as the Lynx, Bravo, TECAN, Hamilton
Preferred Qualifications
-
Prior experience onboarding assays onto robotic platforms (e.g., translating a manual SEC-MALS or ELISA to a liquid handler).
-
Experience with mass spectrometry (LC-MS) for confirming chain pairing in multi-specific formats.
-
Familiarity with Python or scheduling software for automation.
Total compensation for this role is market driven, with a starting salary of $100k+, as well as company stock awards. Base pay is ultimately determined based on a candidate's skills, expertise, and experience. We also offer a comprehensive benefits package including medical, dental & vision coverage, health spending accounts, voluntary benefits, leave of absence policies, Employee Assistance Program, 401(k) program with employer contribution, 8 paid holidays in addition to a full-week winter shutdown and unlimited Paid Time Off policy.
Ginkgo has implemented a return to office policy effective October 1, 2025 with required in-office days 3x per week on Tuesday, Wednesday, Thursday. Some teams may require to be onsite 4-5 days per week and this will be discussed as part of the interview process. This policy applies to all employees who live within 50 miles of Ginkgo’s offices in Boston, MA, Emeryville, CA and West Sacramento, CA.
It is the policy of Ginkgo Bioworks to provide equal employment opportunities to all employees, employment applicants, and EOE disability/vet.
Privacy Notice
I understand that I am applying for employment with Ginkgo Bioworks and am being asked to provide information in connection with my application. I further understand that Ginkgo gathers this information through a third-party service provider and that Ginkgo may also use other service providers to assist in the application process. Ginkgo may share my information with such third-party service providers in connection with my application and for the start of employment. Ginkgo will treat my information in accordance with Ginkgo's Privacy Policy. By submitting this job application, I am acknowledging that I have reviewed and agree to Ginkgo's Privacy Policy as well as the privacy policies of the third-party service providers used by Ginkgo's associated with the application process.
総閲覧数
0
応募クリック数
0
模擬応募者数
0
スクラップ
0
類似の求人

Model Validation 2nd LOD Senior Analyst
Citigroup · TAMPA, Florida, United States of America

Senior QA Analyst, Database Platform
Keeper · Remote, US

Fellow, Datacenter Infrastructure & Quality Excellence
AMD · Austin

Trust and Safety - Senior Data Scientist
Scale AI · San Francisco, CA

Principal Researcher (League of Legends PubSports) - Central Product Insights
Riot Games · Los Angeles, USA
Ginkgo Bioworksについて

Ginkgo Bioworks
PublicGinkgo Bioworks is a synthetic biology company that designs custom microbes for customers across multiple markets including pharmaceuticals, agriculture, and industrial chemicals. The company operates automated foundries to engineer biological systems at scale.
501-1,000
従業員数
Boston
本社所在地
$2.5B
企業価値
レビュー
3.8
10件のレビュー
ワークライフバランス
2.8
報酬
2.5
企業文化
4.2
キャリア
3.5
経営陣
3.8
65%
友人に勧める
良い点
Cutting-edge technology and innovative projects
Supportive team and friendly coworkers
Good benefits and flexible hours
改善点
Fast-paced and demanding environment
Compensation below industry standard
Long hours and overwhelming workload
給与レンジ
0件のデータ
N/A
N/A · N/A
0件のレポート
$144,218
年収総額
基本給
-
ストック
-
ボーナス
-
$122,585
$165,851
ニュース&話題
DNA (NYSE: DNA) Form 144: Proposed sale of 324 Class A shares, insider sales listed - Stock Titan
Stock Titan
News
·
1w ago
Ginkgo Bioworks (NYSE: DNA) CFO nets PSU shares, sells stock for taxes - Stock Titan
Stock Titan
News
·
1w ago
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says - drugdiscoverytrends.com
drugdiscoverytrends.com
News
·
1w ago
Vanguard shows 0% stake in Ginkgo Bioworks (NYSE: DNA) after realignment - Stock Titan
Stock Titan
News
·
4w ago